Zobrazeno 1 - 10
of 642
pro vyhledávání: '"Pedreira, CE"'
Autor:
da Costa, Elaine Sobral, Peres, Rodrigo Tosta, Almeida, Julia, Lécrevisse, Quentin, Arroyo, María Elena, Teodósio, Cristina, Pedreira, Carlos Eduardo, van Dongen, Jacques J. M., Orfao, Alberto
Publikováno v:
Cytometry Part B: Clinical Cytometry; January 2010, Vol. 78 Issue: 1 p11-20, 10p
Autor:
Pérez-Pons A; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain., Teodosio C; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Jara-Acevedo M; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.; Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain., Henriques A; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, CIBERONC, Toledo, Madrid, Spain.; Cytognos SL, Salamanca, Spain., Navarro-Navarro P; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.; Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain., García-Montero AC; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain., Álvarez-Twose I; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, CIBERONC, Toledo, Madrid, Spain., Lecrevisse Q; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Fluxa R; Cytognos SL, Salamanca, Spain., Sánchez-Muñoz L; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, CIBERONC, Toledo, Madrid, Spain., Caldas C; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain., Pozo J; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Martín S; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain., Sanfeliciano TC; Department of Biochemistry, University Hospital of Salamanca, Salamanca, Spain., Pedreira CE; Systems and Computing Department (PESC), COPPE, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., Botafogo V; Department of Hematology and Hemotherapy, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., González-López O; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain., Mayado A; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain., Orfao A; Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.
Publikováno v:
Allergy [Allergy] 2024 Jul; Vol. 79 (7), pp. 1921-1937. Date of Electronic Publication: 2024 Feb 01.
Autor:
Sgariglia D; Engenharia de Sistemas e Computação, COPPE-UFRJ, Rio de Janeiro, Brazil., Carneiro FRG; Center of Technological Development in Health (CDTS), FIOCRUZ, Rio de Janeiro, Brazil; Laboratório Interdisciplinar de Pesquisas Médicas Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil; Program of Immunology and Tumor Biology, Brazilian National Cancer Institute(INCA), Rio de Janeiro 20231050, Brazil., Vidal de Carvalho LA; Faculdade de Medicina, UFRJ, Rio de Janeiro, Brazil., Pedreira CE; Engenharia de Sistemas e Computação, COPPE-UFRJ, Rio de Janeiro, Brazil., Carels N; Platform of Biological System Modeling, Center of Technological Development in Health (CDTS), FIOCRUZ, Rio de Janeiro, Brazil., da Silva FAB; Scientific Computing Program (PROCC), FIOCRUZ, Rio de Janeiro, Brazil. Electronic address: fabricio.silva@fiocruz.br.
Publikováno v:
Computational biology and chemistry [Comput Biol Chem] 2024 Apr; Vol. 109, pp. 108022. Date of Electronic Publication: 2024 Feb 07.
Autor:
Lhermitte L; Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris, Paris, France., Barreau S; Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris, Paris, France., Morf D; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland., Fernandez P; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland., Grigore G; Cytognos SL, Salamanca, Spain., Barrena S; Cytognos SL, Salamanca, Spain.; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., de Bie M; Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Flores-Montero J; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Mejstrikova E; Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Burgos L; Applied Medical Research Center (CIMA), IDISNA, Clinica Universidad de Navarra (UNAV), Pamplona, Spain., Caetano J; Hemato-Oncology Laboratory, Portuguese Institute of Oncology, Lisbon, Portugal., Gaipa G; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, MB, Italy., Buracchi C; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, MB, Italy., da Costa ES; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Av. Horacio Macedo, Predio do CT, CEP, Rio de Janeiro, 21941-914, Brazil., Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland., Szczepański T; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland., Aanei CM; Laboratory of Hematology, University Hospital of Saint-Etienne, Saint-Etienne, France., van der Sluijs-Gelling A; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands., Delgado AH; Cytognos SL, Salamanca, Spain.; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Fluxa R; Cytognos SL, Salamanca, Spain., Lecrevisse Q; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Pedreira CE; Systems and Computing Department (PESC), COPPE, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., van Dongen JJM; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands., Orfao A; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., van der Velden VHJ; Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. v.h.j.vandervelden@erasmusmc.nl.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2021 Jan; Vol. 34 (1), pp. 59-69. Date of Electronic Publication: 2020 Sep 30.
Autor:
Nascimento ERdS, Débora S. Faffe, Lessa Fs, Galiez RdM, Ferreira Fa, Cotta-Pereira Smr, Pedreira Ce, Diana Mariani, Lessa Ma, Leitao IdC, Castineira Tmpp, Succi Ib
BackgroundDuring the COVID-19 pandemic, olfactory dysfunction (anosmia or hyposmia) has been reported by many patients and recognized as a prevalent and early symptom of infection. This finding has been associated with viral-induced olfactory neuron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::819d8a1e1140c0e270a7d8962d02eb79
https://doi.org/10.1101/2021.01.20.21250173
https://doi.org/10.1101/2021.01.20.21250173
Autor:
Landeira-Viñuela A; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Alcoceba-Sanchez M; Department of Hematology, Center Research-Centre IBMCC (CSIC-USAL, IBSAL), University Hospital of Salamanca, CIBERONC-CB16/12/00233, 37007 Salamanca, Spain., Navarro-Bailón A; Department of Hematology, Center Research-Centre IBMCC (CSIC-USAL, IBSAL), University Hospital of Salamanca, CIBERONC-CB16/12/00233, 37007 Salamanca, Spain., Arias-Hidalgo C; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Juanes-Velasco P; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Sánchez-Santos JM; Statistics Department, University of Salamanca, 37008 Salamanca, Spain., Lecrevisse Q; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Pedreira CE; Systems and Computing Department (COPPE-PESC), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-914, Brazil., García-Vaquero ML; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Hernández ÁP; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain.; Organic Chemistry Section, Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Salamanca, Campus Miguel de Unamuno s/n, 37008 Salamanca, Spain., Montalvillo E; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Góngora R; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., De Las Rivas J; Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), 37008 Salamanca, Spain., González-Díaz M; Department of Hematology, Center Research-Centre IBMCC (CSIC-USAL, IBSAL), University Hospital of Salamanca, CIBERONC-CB16/12/00233, 37007 Salamanca, Spain., Orfao A; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain., Fuentes M; Department of Medicine and General Service of Cytometry, CIBERONC-CB16/12/00400, Cancer Research Centre-IBMCC, CSIC-USAL, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain.; Proteomics Unit, Cancer Research Centre-IBMCC, IBSAL, Campus Miguel de Unamuno s/n, University of Salamanca-CSIC, 37008 Salamanca, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jan 31; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 31.
Autor:
Landeira-Viñuela A; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Arias-Hidalgo C; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Juanes-Velasco P; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Alcoceba M; Department of Hematology, University Hospital of Salamanca, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00233, Center Research-Centre Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC) Consejo Superior de Investigaciones Científicas - Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (CSIC-USAL, IBSAL), Salamanca, Spain., Navarro-Bailón A; Department of Hematology, University Hospital of Salamanca, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00233, Center Research-Centre Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC) Consejo Superior de Investigaciones Científicas - Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (CSIC-USAL, IBSAL), Salamanca, Spain., Pedreira CE; Systems and Computing Department Instituto Alberto Luiz Coimbra de Pós-Graduação e Pesquisa de Engenharia-Programa de Engenharia de Sistemas e Computação (COPPE-PESC), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil., Lecrevisse Q; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Díaz-Muñoz L; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Sánchez-Santos JM; Statistics Department, University of Salamanca, Salamanca, Spain., Hernández ÁP; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Department of Pharmaceutical Sciences, Organic Chemistry Section, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain., García-Vaquero ML; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Góngora R; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., De Las Rivas J; Bioinformatics and Functional Genomics Group, Cancer Research Center Instituto Universitario de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas/Universidad de Salamanca (CIC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain., González M; Department of Hematology, University Hospital of Salamanca, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00233, Center Research-Centre Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC) Consejo Superior de Investigaciones Científicas - Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (CSIC-USAL, IBSAL), Salamanca, Spain., Orfao A; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Fuentes M; Department of Medicine and General Service of Cytometry, Centro de Investigación Biomédica en Red Cáncer (CIBERONC)- CB16/12/00400, Cancer Research Centre-Instituto Universitario de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas - Universidad de Salamanca (CSIC-USAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Proteomics Unit, Cancer Research Centre-IBMCC, Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca-Consejo Superior de Investigaciones Científicas (CSIC), Salamanca, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Sep 28; Vol. 13, pp. 965905. Date of Electronic Publication: 2022 Sep 28 (Print Publication: 2022).
Autor:
Pérez-Pons A; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Jara-Acevedo M; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Sequencing Service (NUCLEUS) Universidad de Salamanca Salamanca Spain., Henriques A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Navarro-Navarro P; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Sequencing Service (NUCLEUS) Universidad de Salamanca Salamanca Spain., García-Montero AC; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Álvarez-Twose I; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Pedreira CE; Systems and Computing Department (PESC) COPPE Federal University of Rio de Janeiro (UFRJ) Rio de Janeiro Brazil., Sánchez-Muñoz L; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Damasceno D; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain., Caldas C; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Muñoz-González JI; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Matito A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Virgen del Valle Hospital Toledo Spain., Flores-Montero J; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain., González-López O; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Criado I; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain., Mayado A; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain., Orfao A; Cancer Research Center (IBMCC, USAL-CSIC) Department of Medicine and Cytometry Service (NUCLEUS) Universidad de Salamanca Salamanca Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain.; Biomedical Research Institute of Salamanca Salamanca Spain.; Spanish Network on Mastocytosis (REMA) Toledo and Salamanca Spain.
Publikováno v:
Clinical and translational allergy [Clin Transl Allergy] 2022 Jun 14; Vol. 12 (6), pp. e12167. Date of Electronic Publication: 2022 Jun 14 (Print Publication: 2022).
Autor:
Brouwer N; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands., Matarraz S; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL) Paseo de la Universidad de Coimbra s/n, Campus Miguel de Unamuno, 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Nierkens S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Hofmans M; Department of Laboratory Medicine, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium., Nováková M; CLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol, V Uvalu 84, 15006 Prague, Czech Republic., da Costa ES; Institute of Pediatrics (IPPMG), Federal University of Rio de Janeiro (UFRJ), R. Bruno Lobo, 50-Cidade Universitária, Rio de Janeiro-RJ 21941-912, Brazil., Fernandez P; Institute for Laboratory Medicine, Kantonsspital Aarau AG, Tellstrasse 25, 5001 Aarau, Switzerland., Bras AE; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands., de Mello FV; Institute of Pediatrics (IPPMG), Federal University of Rio de Janeiro (UFRJ), R. Bruno Lobo, 50-Cidade Universitária, Rio de Janeiro-RJ 21941-912, Brazil., Mejstrikova E; CLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol, V Uvalu 84, 15006 Prague, Czech Republic., Philippé J; Department of Diagnostic Sciences, Ghent University, C. Heymanslaan 10, 9000 Ghent, Belgium., Grigore GE; Cytognos SL, Carretera de Madrid Km. 0 Nave 9, Pol. La Serna, 37900 Salamanca, Spain., Pedreira CE; Systems and Computing Department, COPPE, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro-RJ 21941-594, Brazil., van Dongen JJM; Department of Immunology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Centro de Investigación del Cancer, Department of Medicine, University of Salamanca, 37007 Salamanca, Spain., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL) Paseo de la Universidad de Coimbra s/n, Campus Miguel de Unamuno, 37007 Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands., On Behalf Of The EuroFlow Consortium
Publikováno v:
Cancers [Cancers (Basel)] 2022 Mar 21; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 21.
Autor:
Böttcher S; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical School, Rostock, Germany., Engelmann R; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical School, Rostock, Germany., Grigore G; Cytognos SL, Salamanca, Spain., Fernandez P; FACS/Stem Cell Laboratory, Kantonsspital Aarau AG, Aarau, Switzerland., Caetano J; Secção de Citometria de Fluxo, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal., Flores-Montero J; Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Novakova M; CLIP - Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Philippé J; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Ritgen M; Department of Internal Medicine II, University of Schleswig-Holstein, Kiel, Germany., Burgos L; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC CB16/12/00369, Pamplona, Spain., Lecrevisse Q; Cytognos SL, Salamanca, Spain.; Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain., Lange S; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical School, Rostock, Germany., Kalina T; CLIP - Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Verde Velasco J; Cytognos SL, Salamanca, Spain., Fluxa Rodriguez R; Cytognos SL, Salamanca, Spain., van Dongen JJM; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands; and., Pedreira CE; Systems and Computing Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Orfao A; Clinical and Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), University of Salamanca, Salamanca, Spain.; Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC) (CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Blood advances [Blood Adv] 2022 Feb 08; Vol. 6 (3), pp. 976-992.